Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Gets FDA OK To Start Pivotal Trial Of CoreValve

This article was originally published in The Gray Sheet

Executive Summary

Medtronic has gained conditional approval from FDA to begin the pivotal trial of its CoreValve transcatheter aortic valve system in the United States, the firm announced Oct. 15.

You may also be interested in...



News In Brief

Roche’s melanoma companion diagnostic approved

News In Brief

Roche’s melanoma companion diagnostic approved

FDA OKs Sapien Valve As Pivotal Trial Control Prior To Marketing Approval

Edwards Lifesciences says FDA will support use of the firm's investigational Sapien transcatheter aortic heart valve as a control treatment in an upcoming trial of the firm’s next-generation Sapien XT.

Related Content

Topics

UsernamePublicRestriction

Register

MT029504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel